Conditions: Non-Small Cell Lung Cancer
Interventions: Drug: Selpercatinib; Drug: Carboplatin; Drug: Cisplatin; Drug: Pemetrexed; Drug: Pembrolizumab
Sponsors: Loxo Oncology, Inc.; Eli Lilly and Company
Active, not recruiting
14677 items (14677 unread) in 74 feeds